Recombinant Human KARS Protein，His

KARS, or lysyl-tRNA synthetase, plays a crucial role in protein synthesis by catalyzing the attachment of lysine to its corresponding tRNA, thus facilitating the translation of genetic information into proteins. Beyond its fundamental role in translation, KARS has emerged as a key player in various cellular processes, including inflammation, immune response, and cellular signaling pathways. Research into KARS has intensified due to its association with several diseases, including cancer and neurodegenerative disorders, where it can exhibit aberrant expression or function. Recent studies have highlighted the potential of KARS as a therapeutic target, as its inhibition could disrupt pathogenic pathways and offer new avenues for treatment. The development of recombinant KARS proteins allows for detailed structural and functional studies, enabling researchers to investigate its mechanism of action and interactions at the molecular level. Moreover, these studies can facilitate the design of small molecules or peptides that modulate KARS activity, ultimately contributing to innovative therapeutic strategies. Thus, KARS and its recombinant forms represent a promising frontier in understanding and targeting complex diseases at the biochemical level, underscoring the importance of this enzyme in both basic and applied biomedical research.